Mednet Logo
HomeNeurologyQuestion

How do you choose between adjuvant PCV vs temozolomide in high risk oligodendroglioma with IDH mutation and 1p/19q co deletion?

1 Answers
Mednet Member
Mednet Member
Medical Oncology · Mayo Clinic

In our practice, we typically offer procarbazine/lomustine (with or without vincristine) to all patients with high risk oligodendroglioma, IDH mutated, 1p/19q codeleted. Temozolomide based on the Stupp regimen is used as an alternative when there are specific concerns for PCV related toxicity or str...

Register or Sign In to see full answer